Only pay if approved·Free shipping·Cancel anytime·Provider supervised·HIPAA secure

Provider-prescribed treatments. Subject to medical evaluation. Medications are dispensed by licensed U.S. pharmacies.

Back to Blog
GLP-1 / Weight Loss
📚 Informational 5/24/2026 7 min readBy EdenRx Medical Team

GLP-1 While Pregnant: Why It's Not Recommended

GLP-1 While Pregnant: Why It's Not Recommended

Ready to find out if you may qualify?

No payment required to start · Takes less than 60 seconds · Only pay if approved

Check Your Eligibility Free
No Payment Required Response Within 24h Built from Eden Med Spa

Key Takeaways

  • 1GLP-1 medications like semaglutide and tirzepatide are not approved for use during pregnancy and should be discontinued at least two months before attempting conception.
  • 2Animal studies have raised concerns about fetal development with GLP-1 use, and human safety data during pregnancy is insufficient.
  • 3Patients in Florida and New York who are postpartum or planning ahead may explore provider-reviewed GLP-1 eligibility through EdenRx after consulting a licensed clinician.

GLP-1 receptor agonists are not recommended during pregnancy, and most clinical guidelines advise discontinuing these medications before conception. If you are pregnant, planning to become pregnant, or think you may be pregnant, it is essential to speak with a licensed medical provider before continuing or starting any GLP-1 therapy.

Ready to find out if you qualify? Start Free Assessment — No payment required.


What Are GLP-1 Medications and How Do They Work?

GLP-1 receptor agonists — including semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) — are injectable medications originally developed to manage type 2 diabetes and now widely used for chronic weight management. They work by mimicking a naturally occurring hormone called glucagon-like peptide-1, which helps regulate blood sugar, slow gastric emptying, and reduce appetite signals in the brain.

These medications have shown meaningful results for weight loss in non-pregnant adults, and interest in them has grown substantially. However, their safety profile during pregnancy is an entirely separate consideration — one that current evidence does not support favorably. Understanding the distinction between how a medication works and whether it is safe in a specific population is critical before starting or continuing any treatment.


Current Evidence on GLP-1 Pregnancy Safety

The available data on GLP-1 pregnancy safety is limited, and that limitation itself is a significant concern. Most clinical trials for semaglutide and tirzepatide explicitly excluded pregnant individuals, meaning there is little human data to draw from. Animal studies, however, have raised flags — some showing associations with fetal growth restriction, skeletal abnormalities, and adverse pregnancy outcomes at doses comparable to human therapeutic levels.

Because of this, the FDA has not approved any GLP-1 receptor agonist for use during pregnancy. Both Novo Nordisk (maker of semaglutide) and Eli Lilly (maker of tirzepatide) recommend that patients discontinue these medications at least two months before attempting conception, given the drugs' long half-lives. If you are currently using a GLP-1 and have questions about semaglutide safety more broadly, a provider-reviewed consultation can help clarify your individual situation.


Why GLP-1s Are Discontinued Before and During Pregnancy

One of the primary reasons GLP-1 medications are discontinued well before pregnancy is their extended half-life. Semaglutide, for example, has a half-life of approximately one week, meaning it can remain active in the body for several weeks after the last dose. This pharmacokinetic profile means that simply stopping the medication when a pregnancy test comes back positive may not be early enough to prevent fetal exposure during critical early development windows.

Additionally, the caloric restriction and potential nausea associated with GLP-1 use could interfere with adequate nutrition during pregnancy — a period when sufficient intake of folate, iron, protein, and calories is essential for healthy fetal development. Weight loss itself is generally not recommended during pregnancy. For these reasons, medical providers consistently advise planning ahead and transitioning off GLP-1 therapy well before conception is attempted.


What Should You Do If You're Using a GLP-1 and Planning to Conceive?

If you are currently enrolled in a weight loss program that includes GLP-1 therapy and you are planning to become pregnant, the most important step is to schedule a conversation with your prescribing provider as soon as possible. They can help you develop a transition plan that accounts for the medication's clearance timeline, your current weight management goals, and any underlying conditions that may require continued attention.

For patients in Florida and New York, EdenRx offers provider-reviewed telehealth consultations that may help you understand your options — whether that means safely tapering off a GLP-1, exploring alternative approaches during the preconception window, or revisiting weight loss support after delivery. Results vary by individual, and any plan should be personalized by a licensed provider. You can explore pricing and program options to understand what may be available to you if and when the time is right to restart care.


Comparing GLP-1 Options: What Matters Before You Start

For individuals who are not pregnant and are evaluating GLP-1 therapy, understanding the differences between available medications is an important part of making an informed decision. Semaglutide and tirzepatide are the two most widely prescribed options, and they differ in their mechanisms, dosing schedules, and side effect profiles. You can read a detailed breakdown in our guide to semaglutide vs. tirzepatide.

What matters most — regardless of which medication may be considered — is that the decision is made with full awareness of your health history, your family planning timeline, and your personal goals. If there is any possibility of pregnancy in the near future, that context must be part of the conversation with your provider before any GLP-1 prescription is written. Eligibility for GLP-1 therapy depends on clinical criteria, and a thorough assessment is the appropriate starting point.


Why Provider Review Matters

Not all telehealth platforms apply the same level of clinical rigor to GLP-1 prescribing. At EdenRx, every patient inquiry is reviewed by a licensed medical provider who evaluates your health history, current medications, and individual risk factors before any treatment is recommended. This provider-first model is especially important when it comes to sensitive situations like pregnancy planning, where a one-size-fits-all approach could carry real consequences.

Provider review also means that patients receive guidance that is personalized and compliant with current clinical standards — not just a prescription generated by an algorithm. If you are unsure whether you qualify, the first step is completing a free assessment, which gives our clinical team the information they need to make an appropriate recommendation. No payment is required to start.

Built from Eden Med Spa — real patients, real treatments.


Thinking about GLP-1 therapy after pregnancy or before you conceive? Explore Your Program Options or Start Your Free Assessment today — available to patients in Florida and New York.


Frequently Asked Questions

Is it safe to take semaglutide while pregnant? No. Semaglutide is not approved for use during pregnancy, and current clinical guidance recommends discontinuing it at least two months before attempting conception. Animal studies have raised concerns about fetal development, and there is insufficient human data to establish safety.

What happens if I accidentally take a GLP-1 while pregnant? If you discover you are pregnant while taking a GLP-1 medication, stop taking it and contact your OB-GYN or prescribing provider immediately. They can assess your situation and advise on next steps based on how far along you are and how recently you took your last dose.

How long should I stop GLP-1 medications before trying to get pregnant? Most clinical guidelines recommend stopping semaglutide at least two months before attempting conception due to its long half-life. Your provider may adjust this recommendation based on the specific medication and your individual health profile.

Can GLP-1 medications affect fertility? Current evidence does not confirm that GLP-1 medications directly impair fertility. However, because weight changes can influence hormonal balance and ovulation, any significant weight loss journey — including one supported by GLP-1 therapy — may have indirect effects. Speak with your provider about your specific situation.

Are there weight management options safe to use during pregnancy? Weight loss is generally not recommended during pregnancy. Nutritional support, prenatal care, and guidance from an OB-GYN are the appropriate frameworks for managing weight during pregnancy. GLP-1 medications and most pharmacological weight loss interventions are not considered appropriate during this time.

When can I restart a GLP-1 after giving birth? The timing for restarting GLP-1 therapy postpartum depends on whether you are breastfeeding, your current health status, and your provider's assessment. These medications are generally not recommended while breastfeeding. Consult with a licensed provider — and if you're in Florida or New York, EdenRx may be able to support your postpartum weight loss journey if you are deemed eligible.


Conclusion

GLP-1 medications have shown real promise for weight management in eligible, non-pregnant adults — but GLP-1 pregnancy safety is a serious and well-established concern. The current medical consensus is clear: these medications should be discontinued well before conception and are not appropriate for use during pregnancy or, typically, while breastfeeding. If you are in a life stage where pregnancy is possible or planned, that conversation must happen with a licensed provider before any GLP-1 therapy begins or continues.

EdenRx is committed to responsible, provider-reviewed telehealth care for patients in Florida and New York. Whether you are exploring your options before pregnancy, after delivery, or at any other stage of your health journey, we are here to help guide you through what may be possible — safely and transparently. Results vary, and all treatment decisions are made in partnership with licensed clinicians.

Take the first step today. Start Your Free Assessment — No payment required. Available to patients in Florida and New York only.

See if you qualify in 60 seconds

Provider-reviewed · Only pay if approved · Cancel anytime

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
GLP-1 semaglutide tirzepatide pregnancy safety weight loss telehealth Florida New York GLP-1 pregnancy safety EdenRx

Share This Article

Share Text

Pregnant or planning to be? GLP-1 meds like semaglutide are NOT recommended during pregnancy. Here's what you need to know about GLP-1 pregnancy safety. 👉 tryedenrx.org

No payment required to start — get up to $50 off your first month.

A licensed provider reviews every case. Only pay if approved. Cancel anytime.

Start Free Medical Assessment
No Payment Required Response Within 24h Built from Eden Med Spa
Live Activity
124 people online now
1,076 visits today
10 orders shipped today
HIPAA Secure